CECILIO GIMÉNEZ
444
41.
Dobbs, D. (2010) Schizophrenia appears during adolescence. But where does one begin
and the other end? Nature 468, 154-‐156.
42.
Beneyto, M. & Lewis DA. (2011) Insights into the neurodevelopmental origin of
schizophrenia from postmortem studies of prefrontal cortical circuitry. International
Journal of Developmental Neuroscience 29, 295-‐304.
43.
Sweet, R. A.; Fish, K. N. & Lewis, D. A. (2010) Mapping Synaptic Pathology within Cerebral
Cortical Circuits in Subjects with Schizophrenia. Frontiers in Human Neuroscience 23, 44-‐
52.
44.
Volk, D. W. & Lewis, D. A. (2010) Prefrontal cortical circuits in schizophrenia. Current
Topics in Behavioral Neuroscience 4, 485-‐508.
45.
Lewis, D. A. (2011) The chandelier neuron in schizophrenia. Developmental Neurobiology
71, 118-‐127.
46.
Piper, M.; Beneyto, M.; Burne, T. H.; Eyles, D. W.; Lewis, D. A. & McGrath, J. J. (2012) The
neurodevelopmental hypothesis of schizophrenia: convergent clues from epidemiology
and neuropathology. Psychiatric Clinical North America 35, 571-‐584.
47.
Lewis, D. A. (2012) Cortical circuit dysfunction and cognitive deficits in schizophrenia:
implications for preemptive interventions. European Journal of Neuroscience 35, 1871-‐
1878.
48.
Glausier, J.R. & Lewis, D. A. (2012) Dendritic spine pathology in schizophrenia.
Neuroscience. [Epub ahead of print] PubMed PMID: 22546337.
49.
Gonzalez-‐Burgos, G. & Lewis, D. A. (2012) NMDA Receptor Hypofunction, Parvalbumin-‐
Positive Neurons, and Cortical Gamma Oscillations in Schizophrenia. Schizophrenia
Bulletin 38, 950-‐957.
50.
Stan, A. D. & Lewis D. A. (2012) Altered cortical GABA neurotransmission in
schizophrenia: Insights into novel therapeutic strategies. Current Pharmological
Biotechnology 13, 1557-‐1562.
51.
Curley, A. A. & Lewis, D.A. (2012) Cortical basket cell dysfunction in schizophrenia.
Journal of Physiology 590 (Pt 4), 715-‐724.
52.
Lewis, D. A.; Curley, A. A.; Glausier, J. R. & Volk, D. W. (2012) Cortical parvalbumin
interneurons and cognitive dysfunction in schizophrenia. Trends in Neuroscience 35, 57-‐
67.
53.
Volk, D. W.; Eggan, S. M. & Lewis, D.A. (2010) Alterations in metabotropic glutamate
receptor1α and regulator of G protein signaling 4 in the prefrontal cortex in
schizophrenia. American Journal of Psychiatry 167, 1489-‐1498.
54.
Gonzalez-‐Burgos, G.; Hashimoto, T. & Lewis, D. A. (2010) Alterations of cortical GABA
neurons and network oscillations in schizophrenia. Current Psychiatry Reports 12, 335-‐
344.
55.
Lewis, D.A. (2009) Neuroplasticity of excitatory and inhibitory cortical circuits in
schizophrenia. Dialogues on Clinical Neuroscience 11, 269-‐80.
56.
Bristol, L. A. & Rothstein, J. D. (1996) Glutamate transporter gene expression in
amyotrophic lateral sclerosis motor cortex. Annals of Neurology 39, 676-‐679.
57.
Zafra, F. & Giménez, C. (2008) Glycine transporters and synaptic function. IUBMB Life 60,
810-‐817.
58.
Aragón, C. & López-‐Corcuera, B. (2005) Glycine transporters: crucial roles of
pharmacological interest revealed by gene deletion. Trends in Pharmacological Sciences
26, 283-‐286.
59.
Aragón, C. & López-‐Corcuera, B. (2003) Structure, function and regulation of glycine
neurotransporters. European Journal of Pharmacology 31, 249-‐262.
